Lab Notes & Best Practices
Guidelines for laboratory documentation, well-plate organization, and reproducible research
Labeling Conventions
Establish consistent naming systems for wells, samples, and controls to prevent confusion and ensure traceability.
- Use alphanumeric coordinates (A1, B2, etc.)
- Maintain consistent abbreviations
- Include batch/lot information
Control Placement
Strategic positioning of positive and negative controls ensures reliable data validation and error detection.
- Distribute controls evenly
- Use multiple replicates
- Avoid edge effects
Documentation Standards
Comprehensive record-keeping supports reproducibility and regulatory compliance in research.
- Date and time stamps
- Operator identification
- Protocol version tracking
Version Control
Track changes to templates and protocols to maintain consistency across experiments and research teams.
- Sequential version numbering
- Change log maintenance
- Archive previous versions
Lab Note Templates
ELISA Experiment Template
ELISA EXPERIMENT LOG ===================== Date: [YYYY-MM-DD] Operator: [Name] Project: [Project Name] Protocol Version: [v1.0] PLATE LAYOUT (96-well): - Samples: A1-A8, B1-B8, C1-C8 - Standards: D1-D8 (serial dilution) - Positive Control: E1-E3 - Negative Control: E4-E6 - Blank Wells: E7-E8 REAGENT INFORMATION: - Primary Antibody: [Catalog #] Lot: [####] Dilution: [1:1000] - Secondary Antibody: [Catalog #] Lot: [####] Dilution: [1:5000] - Substrate: [Type] Lot: [####] - Buffer: [Type] pH: [7.4] PROCEDURE NOTES: 1. Plate coating: Overnight at 4°C 2. Blocking: 1hr at RT with 5% BSA 3. Primary incubation: 2hr at RT 4. Secondary incubation: 1hr at RT 5. Development: 15min in dark OBSERVATIONS: - [Note any deviations from protocol] - [Record any unusual observations] RESULTS: - Positive controls performed as expected: [Y/N] - Negative controls within acceptable range: [Y/N] - Standard curve R²: [value] - Sample results: [attach data file] NEXT STEPS: - [Plan for follow-up experiments] - [Any protocol modifications needed]
Cell Culture Viability Assay
CELL VIABILITY ASSAY LOG ======================== Date: [YYYY-MM-DD] Operator: [Name] Cell Line: [Name/Passage #] Plate Type: 96-well, tissue culture treated EXPERIMENTAL DESIGN: - Treatment Groups: Compounds A, B, C - Concentrations: 10μM, 1μM, 0.1μM, 0.01μM - Controls: Vehicle (DMSO), Untreated - Replicates: n=6 per condition - Total Wells Used: 72 PLATE MAP (96-well): Row A-C: Compound A (triplicate concentrations) Row D-F: Compound B (triplicate concentrations) Row G-H: Compound C, Controls, Blanks CELL SEEDING: - Density: 5,000 cells/well - Volume: 100μL/well - Media: DMEM + 10% FBS - Seeding Date: [YYYY-MM-DD] TREATMENT CONDITIONS: - Treatment Start: 24hr post-seeding - Treatment Duration: 48hr - Final DMSO Concentration: <0.1% ASSAY PROCEDURE: - MTT addition: 20μL/well (5mg/mL) - Incubation: 4hr at 37°C, 5% CO₂ - Solubilization: 100μL DMSO - Reading: 570nm absorbance QUALITY CONTROLS: - Untreated Control Viability: [%] - Vehicle Control Viability: [%] - Positive Control (if used): [result] RESULTS SUMMARY: - IC₅₀ Values: [Compound A: X μM, Compound B: Y μM, Compound C: Z μM] - Statistical Analysis: [Method used] - Data File: [filename.xlsx]
qPCR Experiment Log
qPCR EXPERIMENT LOG =================== Date: [YYYY-MM-DD] Operator: [Name] Instrument: [Model] Protocol: [Name v1.0] SAMPLE INFORMATION: - Sample Type: [cDNA/gDNA/RNA] - Extraction Date: [YYYY-MM-DD] - Storage: -80°C - Sample IDs: [S1, S2, S3...] PRIMER INFORMATION: Target Gene 1: [Gene Name] - Forward: [Sequence] Tm: [°C] - Reverse: [Sequence] Tm: [°C] - Product Size: [bp] Reference Gene: [Gene Name] - Forward: [Sequence] Tm: [°C] - Reverse: [Sequence] Tm: [°C] - Product Size: [bp] REACTION SETUP (per well): - Master Mix: [Type] 10μL - Primer Mix (F+R): 1μL each - Template: 1μL - Water: 7μL - Total Volume: 20μL PLATE LAYOUT: - Samples: A1-H6 (target gene) - Samples: A7-H12 (reference gene) - No Template Controls: G7, H7, G12, H12 - Standards: (if applicable) CYCLING CONDITIONS: - Initial Denaturation: 95°C, 10min - Cycling: 40 cycles - Denaturation: 95°C, 15sec - Annealing: [°C], 30sec - Extension: 72°C, 30sec - Melt Curve: 65-95°C QUALITY CONTROLS: - NTC Ct Values: [Should be >35 or undetermined] - Reference Gene Stability: [acceptable range] - Amplification Efficiency: [90-110%] - R² Value: [>0.99] RESULTS: - Average Ct Values: [table/file reference] - ΔΔCt Analysis: [method used] - Fold Change: [results summary] - Statistical Analysis: [method, p-values] DATA FILES: - Raw Data: [filename.eds/.xml] - Analysis: [filename.xlsx] - Plots: [filename.pdf]
Plate Mapping Checklist
Pre-Experiment Planning
Layout Design
Documentation
Quality Control
Post-Experiment
Additional Resources
Statistical Considerations
- Minimum 3 replicates per condition
- Power analysis for sample size
- Appropriate statistical tests
- Multiple comparison corrections
Regulatory Guidelines
- GLP compliance requirements
- FDA guidance documents
- ICH guidelines for validation
- Data integrity principles
Common Pitfalls
- Insufficient controls
- Edge effect neglect
- Poor randomization
- Inadequate documentation